NBC Securities’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$303K Buy
5,250
+97
+2% +$5.57K 0.02% 705
2026
Q1
$313K Buy
5,153
+179
+4% +$10.4K 0.02% 684
2025
Q4
$268K Buy
4,974
+311
+7% +$15K 0.02% 730
2025
Q3
$210K Sell
4,663
-4,402
-49% -$206K 0.02% 817
2025
Q2
$419K Sell
9,065
-1,156
-11% -$56.7K 0.03% 554
2025
Q1
$623K Buy
10,221
+10,211
+102,110% +$595K 0.05% 370
2024
Q4
$619 Sell
10
-10,983
-100% -$614K 0.06% 380
2024
Q3
$568K Buy
10,993
+139
+1% +$6.52K 0.05% 415
2024
Q2
$450K Sell
10,854
-4,264
-28% -$191K 0.04% 474
2024
Q1
$819K Buy
15,118
+3,169
+27% +$161K 0.08% 287
2023
Q4
$613K Buy
11,949
+3,724
+45% +$195K 0.06% 344
2023
Q3
$477K Buy
+8,225
New +$504K 0.05% 398

Other funds holding BMY

NBC Securities's BMY Position: Q2 2026 in Review

NBC Securities increased its Bristol-Myers Squibb (BMY) stake by 1.9% in Q2 2026, buying an estimated $5.57K and bringing the position to 5,250 shares worth $303K. The position accounts for 0.02% of the portfolio, ranked #705.

NBC Securities first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. The position peaked at $819K in Q1 2024. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • NBC Securities held 5,250 shares of Bristol-Myers Squibb worth $303K as of Q2 2026.
  • NBC Securities bought 97 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.57K.
  • Bristol-Myers Squibb made up 0.02% of NBC Securities's portfolio in Q2 2026, its #705 holding.
  • NBC Securities first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
  • NBC Securities's Bristol-Myers Squibb position peaked at $819K in Q1 2024.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.